Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

NIAID Glossary of Funding and Policy Terms and Acronyms—W

For Institute program-specific acronyms, go to NIAID Profile and Fact Book.

#   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z

Term Definition

For grant applications, result of or eRA Commons validation that may require the applicant's attention although it does not stop an application from becoming final, i.e., moving to the Center for Scientific Review. Also see error.

Go to these NIAID resources:


Exception to an NIAID grant policy that NIAID approves when highly beneficial to either the Institute or a project's scientific goals or fiscal stewardship. See deviation.

Go to this NAID resource: Deviations and Waivers to Grant Policies SOP.


Human subjects term indicating a person having origins in any of the original peoples of Europe, the Middle East, or North Africa.

See human subjects, Planned Enrollment Report and Cumulative Inclusion Enrollment Report.


See World Health Organization.

withholding of support

Decision by NIH not to make a noncompeting award for an ongoing grant.


Group that NIH policy requires to be included in clinical research barring a compelling rationale not to do so.

See human subjects, Planned Enrollment Report, and Cumulative Inclusion Enrollment Report.

World Health Organization (WHO)

United Nations agency for world health. Go to WHO.

#   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z

Last Updated December 18, 2014

Last Reviewed June 11, 2012